Rare diseases
Investigational molecules
Locations
18702 North Creek Parkway Suite 100, 98011-8019, United States
Clinical research in progressing desmoid tumors is a central focus, with attention to disease control and long-term management in patients with locally aggressive tumor growth. The sponsor’s studies in this area reflect interest in tumor progression and treatment response within rare fibroblastic and connective tissue disorders.
These research efforts are directed toward therapeutic options for a rare oncology population with limited treatment alternatives.
Immunome Inc. runs clinical trials in conditions such as Desmoid tumour, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
